))
As a patient focused, discovery driven company, Exagen’s AVISE tests are built on a robust foundation of evidence. The Exagen Evidence Journey Podcast Series explores research, conclusive results, and findings from studies using AVISE testing.
…
continue reading
1
Tyler O’Malley on Validation of CB-CAPs Distinguishing SLE from Fibromyalgia
17:46
17:46
Play later
Play later
Lists
Like
Liked
17:46
How can a multianalyte assay panel help distinguish SLE from fibromyalgia and chronic localized pain? And what impact does this have on rheumatologists working to help determine their patients’ conditions? Join Exagen and Tyler O’Malley, Senior Director of Clinical Affairs for Exagen, as he breaks down the abstract, Multi-Center Validation of Cell-…
…
continue reading
1
Dr. Jen Rogers on the Use of CB-CAPs to Assess Disease Activity in SLE
15:59
15:59
Play later
Play later
Lists
Like
Liked
15:59
What is the Type 1 vs Type 2 Lupus Model? How does it shape the care and management of lupus patients? And what impact does it have on the future of drug development to address Type 2 symptoms? Join Exagen and Dr. Jen Rogers, Director of the Duke Lupus Clinic as she breaks down the abstract, The Use of Cell-bound Complement Activation Product to As…
…
continue reading
1
Dr. Anca Askanase on PC4d Predicting Thrombotic Events in SLE
20:33
20:33
Play later
Play later
Lists
Like
Liked
20:33
How does PC4d aid in the prediction of future thrombotic events in those with SLE? And how can it be utilized by clinicians to help their lupus patients? Join Exagen and Dr. Anca Askanase, founder and clinical director of Columbia’s new Lupus Center and the director of Rheumatology Clinical Trials, as she breaks down the abstract, Role of PC4d in P…
…
continue reading
